Abstract Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-β (Aβ) deposition, tau pathology, synaptic dysfunction, neuroinflammation, and metabolic impairment. Increasing evidence suggests that bile acids, traditionally recognized for their roles in lipid digestion and hepatic metabolism, act as endocrine signaling molecules that influence central nervous system (CNS) homeostasis. Through enterohepatic circulation and microbiota-dependent biotransforma
Bile acids in Alzheimer’s disease: a double-edged sword in gut–liver–brain signaling and neurodegeneration
Rehana Basri·Gaber El-Saber Batiha·Mubarak Alruwaili·Ali I. Al-Gareeb·Ali K. Albuhadily·Αθανάσιος Αλεξίου·Marios Papadakis·Safaa A. Faheem·Hayder M. Al-kuraishy
